Sprint Bioscience AB's market cap is currently €5.37M. The company's EPS TTM is €-0.007544285; its P/E ratio is ―; Sprint Bioscience AB is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
